|
Fluticasone furoate impurity EP-ZF; Propan-2-yl 6α,9-difluoro-17α-[(furan-2-ylcarbonyl)oxy]-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-diene-17-carboxylate
|
糠酸氟替卡松雜質(zhì)EP-ZF
|
|
|
Budesonide impurity C
|
布地奈德EP-ZC
|
1040085-99-1
|
|
Fluticasone Trioxo Impurity
|
布地奈德EP-ZN
|
5541-37-7
|
|
Axitinib impurity D
|
阿西替尼雜質(zhì)D
|
944835-85-2
|
|
Budesonide impurity J
|
布地奈德EP-ZJ
|
313474-59-8
|
|
Fluticasone furoate impurity EP-ZG
|
糠酸氟替卡松雜質(zhì)EP-ZG
|
785806-96-4
|
|
Levetiracetam impurity 08
|
左乙拉西坦雜質(zhì)雜質(zhì)08
|
81107-75-7
|
|
Fluticasone furoate impurity EP-ZL; [6α,9-Difluoro-11β,17α-dihydroxy-16α-methyl-3-oxoandrosta-1,4-dien-17-yl][6α,9-difluoro-17α-[(furan-2-ylcarbonyl)oxy]-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-dien-17-yl]dithioperoxyanhydride
|
糠酸氟替卡松雜質(zhì)EP-ZL
|
|
|
Fluticasone furoate impurity EP-ZH; 6α-Chloro-9-fluoro-17-[[(fluoromethyl)sulfanyl]carbonyl]-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-dien-17α-yl furan-2-carboxylate
|
糠酸氟替卡松雜質(zhì)EP-ZH
|
|
|
Budesonide impurity E
|
布地奈德EP-ZE
|
131918-64-4
|
|
Budesonide impurity D
|
布地奈德EP-ZD
|
85234-63-5
|
|
Rosuvastatin calcium impurity C
|
瑞舒伐他汀鈣EP-ZC
|
1422619-13-3
|
|
Axitinib impurity H
|
阿西替尼雜質(zhì)H
|
1443118-73-7
|
|
Levetiracetam impurity 10; diethyl 4,4'-((1-methoxy-1-oxobutan-2-yl)azanediyl)dibutyrate
|
左乙拉西坦雜質(zhì)雜質(zhì)10
|
|
|
Letrozole impurity 05
|
來曲唑雜質(zhì)05
|
2500927-47-7
|
|
Phenylephrine impurity A
|
苯腎上腺素雜質(zhì)01
|
71786-67-9
|
|
fluticasone propionate impurity EP-ZE
|
丙酸氟替卡松雜質(zhì)E
|
105613-90-9
|
|
Levetiracetam impurity 04
|
左乙拉西坦雜質(zhì)雜質(zhì)04
|
102767-31-7
|
|
fluticasone propionate impurity EP-ZH
|
丙酸氟替卡松雜質(zhì)H
|
201812-64-8
|
|
Budesonide impurity B
|
布地奈德EP-ZB
|
1040085-98-0
|
|
Vortioxetine Sulfone
|
沃替西汀雜質(zhì)D
|
1639263-80-1
|
|
Axitinib impurity G
|
阿西替尼雜質(zhì)G
|
1428728-83-9
|
|
Phenylephrine impurity D
|
苯腎上腺素雜質(zhì)04
|
636-87-3
|
|
Palbociclib impurity 02
|
帕布昔利布雜質(zhì)02
|
571191-15-6
|
|
Fluticasone furoate impurity EP-ZA
|
糠酸氟替卡松雜質(zhì)EP-ZA
|
397864-63-0
|
|
Fluticasone furoate impurity EP-ZE
|
糠酸氟替卡松雜質(zhì)EP-ZE
|
398454-97-2
|
|
11-Oxo-Fluticasone Furoate
|
糠酸氟替卡松雜質(zhì)-12
|
397864-57-2
|
|
Budesonide impurity F
|
布地奈德EP-ZF
|
638-94-8
|
|
Letrozole impurity 07
|
來曲唑雜質(zhì)07
|
2451658-74-3
|
|
Phenylephrine impurity B
|
苯腎上腺素雜質(zhì)02
|
94240-17-2
|
|
Olanzapine impurity B
|
奧氮平EP-ZB
|
221176-49-4
|
|
Olanzapine impurity A
|
奧氮平EP-ZA
|
138564-59-7
|
|
Levetiracetam impurity 05
|
左乙拉西坦雜質(zhì)雜質(zhì)05
|
1342229-32-6
|
|
Fluticasone furoate impurity EP-ZB
|
糠酸氟替卡松雜質(zhì)EP-ZB
|
80474-24-4
|
|
fluticasone propionate impurity EP-ZD
|
丙酸氟替卡松雜質(zhì)D
|
73205-13-7
|
|
Levetiracetam impurity 06
|
左乙拉西坦雜質(zhì)雜質(zhì)06
|
1543353-92-9
|
|
Budesonide impurity H
|
布地奈德EP-ZH
|
313474-58-7
|
|
Budesonide impurity I
|
布地奈德EP-ZI
|
113930-13-5
|
|
Palbociclib impurity 09
|
帕布昔利布雜質(zhì)09
|
1922954-32-2
|
|
Palbociclib impurity 11
|
帕布昔利布雜質(zhì)11
|
2206135-30-8
|
|
3-Bromo-vortioxetine Hydrobromide
|
沃替西汀雜質(zhì)C
|
2725536-51-4
|
|
Rosuvastatin calcium impurity E
|
瑞舒伐他汀鈣EP-ZE
|
2226413-61-0
|
|
Olanzapine impurity F
|
奧氮平EP雜質(zhì)6
|
138564-60-0
|
|
Levetiracetam impurity A
|
左乙拉西坦雜質(zhì)雜質(zhì)EP-ZA
|
67118-31-4
|
|
Fluticasone furoate impurity EP-ZJ; 6α,9-Difluoro-17-[[(fluoromethyl)sulfanyl]carbonyl]-11β-hydroxy-16α-methyl-3-oxoandrosta-1,4-dien-17α-yl 5-chlorofuran-2-carboxylate
|
糠酸氟替卡松雜質(zhì)EP-ZJ
|
|
|
Letrozole impurity 08; 1-(bis(4-cyanophenyl)methyl)-1H-1,2,4-triazole 4-oxide
|
來曲唑雜質(zhì)08
|
|
|
Rosuvastatin calcium impurity F
|
瑞舒伐他汀鈣EP-ZF
|
289042-12-2
|
|
Phenylephrine impurity C
|
苯腎上腺素雜質(zhì)03
|
1159977-09-9
|
|
Palbociclib impurity 54
|
帕布昔利布雜質(zhì)54
|
1082876-26-3
|
|
Olanzapine impurity C
|
奧氮平EP-ZC
|
719300-59-1
|
|
Rosuvastatin calcium impurity D
|
瑞舒伐他汀鈣EP-ZD
|
1422954-11-7
|
|
Palbociclib impurity 13
|
帕布昔利布雜質(zhì)13
|
1651214-74-2
|
|
Fluticasone Furoate Trisulphane
|
糠酸氟替卡松雜-14
|
|
|
fluticasone propionate impurity EP-ZB
|
丙酸氟替卡松雜質(zhì)B
|
948566-12-9
|
|
Axitinib impurity I
|
阿西替尼雜質(zhì)I
|
1348536-59-3
|
|
Palbociclib impurity 10
|
帕布昔利布雜質(zhì)10
|
2204863-06-7
|
|
Levetiracetam impurity C
|
左乙拉西坦雜質(zhì)雜質(zhì)EP-ZC
|
3886-69-9
|
|
Palbociclib impurity 03
|
帕布昔利布雜質(zhì)03
|
2324831-15-2
|
|
1,4-Bis[2-[(2,4-dimethylphenyl)thio]phenyl]piperazine
|
沃替西汀雜質(zhì)G
|
2243045-82-9
|
|
Axitinib impurity C
|
阿西替尼雜質(zhì)C
|
1959572-98-5
|
|
Phenylephrine impurity E
|
苯腎上腺素雜質(zhì)05
|
38396-89-3
|
|
Axitinib impurity E
|
阿西替尼雜質(zhì)E
|
885126-34-1
|
|
fluticasone propionate impurity EP-ZI
|
丙酸氟替卡松雜質(zhì)I
|
960071-64-1
|
|
Olanzapine impurity H
|
奧氮平EP雜質(zhì)8
|
935272-10-9
|
|
N-formyl Vortioxetine
|
沃替西汀雜質(zhì)A
|
2135576-73-5
|
|
Palbociclib impurity 07
|
帕布昔利布雜質(zhì)07
|
827022-35-5
|
|
Rosuvastatin calcium impurity A
|
瑞舒伐他汀鈣EP-ZA
|
1715120-13-0
|
|
N-Acetyl Vortioxetine
|
沃替西汀雜質(zhì)F
|
1801352-86-2
|
|
Levetiracetam impurity 11
|
左乙拉西坦雜質(zhì)雜質(zhì)11
|
93778-15-5
|
|
Phenylephrine impurity F; 3-(2,2-dibromoacetyl)phenyl acetate
|
苯腎上腺素雜質(zhì)06
|
|
|
Palbociclib impurity01; 6-acetyl-8-cyclopentyl-2-((5-(ethylamino)pyridin-2-yl)amino)-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one
|
帕布昔利布雜質(zhì)01
|
|
|
Desethylene Vortioxetine
|
沃替西汀雜質(zhì)E
|
2831955-36-1
|
|
Desonide 21-Acetate
|
布地奈德EP-ZM
|
25092-25-5
|
|
Budesonide impurity A
|
布地奈德EP-ZA
|
13951-70-7
|
|
Axitinib impurity B
|
阿西替尼雜質(zhì)B
|
1443118-71-5
|
|
Levetiracetam impurity 09
|
左乙拉西坦雜質(zhì)雜質(zhì)09
|
1868118-63-1
|
|
fluticasone propionate impurity EP-ZA
|
丙酸氟替卡松雜質(zhì)A
|
65429-42-7
|
|
Olanzapine impurity D
|
奧氮平EP-ZD
|
174794-02-6
|
|
Phenylephrine impurity H
|
苯腎上腺素雜質(zhì)08
|
1477-63-0
|
|
Olanzapine impurity E
|
奧氮平EP雜質(zhì)5
|
161696-76-0
|
|
3-[(2,4-Dimethylphenyl)thio]benzenamine
|
沃替西汀雜質(zhì)K
|
1184281-83-1
|
|
Budesonide impurity K
|
布地奈德EP-ZK
|
51333-05-2
|
|
Fluticasone propionate impurity EP-ZG
|
丙酸氟替卡松雜質(zhì)G
|
220589-37-7
|
|
Axitinib impurity F
|
阿西替尼雜質(zhì)F
|
885126-40-9
|
|
Palbociclib impurity 12
|
帕布昔利布雜質(zhì)12
|
2174002-29-8
|
|
Rosuvastatin calcium impurity J
|
瑞舒伐他汀鈣EP-ZJ
|
2226413-62-1
|
|
Fluticasone Furoate 1,2 Dihydro Sulfenic Acid
|
糠酸氟替卡松雜質(zhì)-13
|
948566-11-8
|
|
Levetiracetam impurity 07
|
左乙拉西坦雜質(zhì)雜質(zhì)07
|
429673-89-2
|
|
Axitinib impurity A
|
阿西替尼雜質(zhì)A
|
1959572-97-4
|
|
Phenylephrine impurity G
|
苯腎上腺素雜質(zhì)07
|
939-38-8
|
|
Chloro Fluticasone Propionate
|
丙酸氟替卡松雜質(zhì)10
|
80486-69-7
|
|
Rosuvastatin calcium impurity B
|
瑞舒伐他汀鈣EP-ZB
|
1094100-06-7
|
|
Budesonide impurity L
|
布地奈德EP-ZL
|
216453-74-6
|
|
fluticasone propionate impurity EP-ZF
|
丙酸氟替卡松雜質(zhì)F
|
1219174-94-3
|
|
Fluticasone Trioxo Impurity
|
丙酸氟替卡松雜質(zhì)11
|
219719-95-6
|
|
Budesonide impurity G
|
布地奈德EP-ZG
|
137174-25-5
|
|
Olanzapine impurity G
|
奧氮平EP雜質(zhì)7
|
1070876-09-3
|
|
Chloro Fluticasone Furoate
|
糠酸氟替卡松雜質(zhì)-11
|
1374153-88-4
|
|
Fluticasone furoate impurity EP-ZI
|
糠酸氟替卡松雜質(zhì)EP-ZI
|
948569-98-0
|
|
N-Methyl Vortioxetine Hydrobromide
|
沃替西汀雜質(zhì)B
|
1293489-87-8
|